Literature DB >> 20349178

Is the beneficial effect of antimuscarinics related to motor or sensory changes in the bladder?

Demetri C Panayi1, Paris Tekkis, Ruwan Fernando, Vikram Khullar.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of the study was to assess the sensory and motor effects of antimuscarinic treatment on the bladder in women with overactive bladder, detrusor overactivity demonstrated on urodynamics and a mean bladder wall thickness (BWT) greater than 5 mm.
METHODS: Fifty-eight women underwent treatment with antimuscarinics in 12 weeks. Before treatment and at 1, 2, 6 and 12 weeks of treatment, women completed the patient perception of bladder condition (PPBC) single-item global questionnaire, indicated the severity of their urgency on a visual analogue scale (VAS) and underwent transvaginal ultrasound to determine mean bladder wall thickness (BWT).
RESULTS: PPBC and VAS scores for urgency declined throughout the treatment course whereas mean BWT declined during the first 6 weeks of treatment and then reached a plateau after falling to below 5 mm.
CONCLUSION: The mechanism of action of antimuscarinics appears to be a complex interaction of sensory and motor components.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349178     DOI: 10.1007/s00192-010-1123-3

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  12 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

2.  A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound.

Authors:  V Khullar; S Salvatore; L Cardozo; T H Bourne; D Abbott; C Kelleher
Journal:  Ultrasound Obstet Gynecol       Date:  1994-05-01       Impact factor: 7.299

3.  Measuring the sensations of urge and bladder filling during cystometry in urge incontinence and the effects of neuromodulation.

Authors:  Sarah Oliver; Clare Fowler; Anthony Mundy; Michael Craggs
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

4.  Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.

Authors:  Paul Abrams; Linda Cardozo; Christopher Chapple; Dzelal Serdarevic; Katherine Hargreaves; Vikram Khullar
Journal:  Int J Urol       Date:  2006-06       Impact factor: 3.369

Review 5.  Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?

Authors:  Steven M Finney; Karl-Erik Andersson; James I Gillespie; Laurence H Stewart
Journal:  BJU Int       Date:  2006-09       Impact factor: 5.588

6.  Ultrasound: a noninvasive screening test for detrusor instability.

Authors:  V Khullar; L D Cardozo; S Salvatore; S Hill
Journal:  Br J Obstet Gynaecol       Date:  1996-09

7.  Overactive bladder symptoms: do we need urodynamics?

Authors:  G Alessandro Digesu; Vik Khullar; Linda Cardozo; Stefano Salvatore
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

Review 8.  Antimuscarinics and overactive bladder: other mechanism of action.

Authors:  Osamu Yamaguchi
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

9.  Cholinergic activation of phasic activity in the isolated bladder: possible evidence for M3- and M2-dependent components of a motor/sensory system.

Authors:  Steven M Finney; Laurence H Stewart; James I Gillespie
Journal:  BJU Int       Date:  2007-07-12       Impact factor: 5.588

10.  Bladder sensory desensitization decreases urinary urgency.

Authors:  Carlos Silva; João Silva; Helder Castro; Frederico Reis; Paulo Dinis; António Avelino; Francisco Cruz
Journal:  BMC Urol       Date:  2007-06-11       Impact factor: 2.264

View more
  8 in total

1.  Scoring for determining effect of antimuscarinics.

Authors:  Viroj Wiwanitkit
Journal:  Int Urogynecol J       Date:  2010-06-19       Impact factor: 2.894

2.  Assessment of bladder wall thickness in women with overactive bladder.

Authors:  Oktay Üçer; Bilal Gümüş; Ali Can Albaz; Gökhan Pekindil
Journal:  Turk J Urol       Date:  2016-06

Review 3.  Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials.

Authors:  Matthias Oelke; Vik Khullar; Hessel Wijkstra
Journal:  World J Urol       Date:  2013-02-06       Impact factor: 4.226

4.  Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.

Authors:  Prashanth Kanagarajah; Rajinikanth Ayyathurai; Daniel J Caruso; Christopher Gomez; Angelo E Gousse
Journal:  Int Urol Nephrol       Date:  2011-06-04       Impact factor: 2.370

Review 5.  Urodynamics in the evaluation of overactive bladder.

Authors:  Eric S Rovner; Colin M Goudelocke
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

6.  The effect of solifenacin on urethral sphincter morphology.

Authors:  Jonathan Duckett; Maya Basu
Journal:  Int Urogynecol J       Date:  2011-04-06       Impact factor: 2.894

7.  A comparative study on the efficacy of solifenacin succinate in patients with urinary frequency with or without urgency.

Authors:  Ji-Yeon Han; Kyu-Sung Lee; Won Hee Park; Choal Hee Park; Jeong Gu Lee; Jeong Zoo Lee; Duk Yoon Kim; Yong Gil Na; Dong Deuk Kwon; Myung-Soo Choo
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 8.  Mirabegron - a selective β3-adrenoreceptor agonist for the treatment of overactive bladder.

Authors:  Alka A Bhide; G Alessandro Digesu; Ruwan Fernando; Vik Khullar
Journal:  Res Rep Urol       Date:  2012-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.